Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

NCT00705783 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

843

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole depot
DRUG: Placebo depot

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.